Aurobindo Pharma reports 34% rise in Q2 consolidated net profit

15 Nov 2016 Evaluate

Aurobindo Pharma has reported results for second quarter ended September 30, 2016.    

The company has reported 22.85% rise in its net profit at Rs 419.24 crore for the quarter under review as compared to Rs 341.27 crore for the same quarter in the previous year. Total income of the company increased by 8.82% at Rs 2413.39 crore for the quarter under review as compared Rs 2217.88 crore for the corresponding quarter previous year.        

On the consolidated basis, the company has reported 33.53% rise in its net profit after tax, minority interest and share of profit of joint ventures at Rs 605.64 crore for the quarter ended September 30, 2016 as compared to Rs 453.55 crore for the same quarter in the previous year. Total Income of the company has increased by 12.03% to Rs 3783.73 crore for quarter under review from Rs 3377.30 crore for the quarter ended September 30, 2015.


Aurobindo Pharma Share Price

1177.60 -39.85 (-3.27%)
08-Dec-2025 15:31 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1790.05
Dr. Reddys Lab 1272.70
Cipla 1498.90
Zydus Lifesciences 920.90
Lupin 2061.50
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×